196 related articles for article (PubMed ID: 21362751)
1. Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.
Somarelli JA; Mesa A; Rodriguez R; Avellan R; Martinez L; Zang YJ; Greidinger EL; Herrera RJ
Lupus; 2011 Mar; 20(3):274-89. PubMed ID: 21362751
[TBL] [Abstract][Full Text] [Related]
2. Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.
Mesa A; Somarelli JA; Wu W; Martinez L; Blom MB; Greidinger EL; Herrera RJ
Lupus; 2013 Nov; 22(13):1371-81. PubMed ID: 24158973
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection.
Newkirk MM; van Venrooij WJ; Marshall GS
Arthritis Res; 2001; 3(4):253-8. PubMed ID: 11438044
[TBL] [Abstract][Full Text] [Related]
4. Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera.
Barakat S; Briand JP; Abuaf N; van Regenmortel MH; Muller S
Clin Exp Immunol; 1991 Oct; 86(1):71-8. PubMed ID: 1717192
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen.
Hof D; Raats JM; Pruijn GJ
Autoimmun Rev; 2005 Jul; 4(6):380-8. PubMed ID: 16081029
[TBL] [Abstract][Full Text] [Related]
6. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.
Kattah NH; Kattah MG; Utz PJ
Immunol Rev; 2010 Jan; 233(1):126-45. PubMed ID: 20192997
[TBL] [Abstract][Full Text] [Related]
7. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.
Ghirardello A; Doria A; Vesco P; Vaccaro E; Bernardi C; Catani C; Fagiolo U; Gambari PF
Rheumatol Int; 1996; 16(4):145-50. PubMed ID: 8961378
[TBL] [Abstract][Full Text] [Related]
8. Mapping epitopes of U1-70K autoantibodies at single-amino acid resolution.
Haddon DJ; Jarrell JA; Diep VK; Wand HE; Price JV; Tangsombatvisit S; Credo GM; Mackey S; Dekker CL; Baechler EC; Liu CL; Varma M; Utz PJ
Autoimmunity; 2015; 48(8):513-23. PubMed ID: 26333287
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins--a link between RA, SLE and MCTD.
Steiner G; Skriner K; Hassfeld W; Smolen JS
Mol Biol Rep; 1996; 23(3-4):167-71. PubMed ID: 9112225
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].
Miyamae T; Ito S; Machida H; Ozawa R; Higuchi R; Nakajima S; Imagawa T; Nakamura T; Mori M; Aihara Y; Ohshige K; Yokota S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):405-14. PubMed ID: 18974625
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
[TBL] [Abstract][Full Text] [Related]
13. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.
Greidinger EL; Zang Y; Jaimes K; Hogenmiller S; Nassiri M; Bejarano P; Barber GN; Hoffman RW
Arthritis Rheum; 2006 Feb; 54(2):661-9. PubMed ID: 16453294
[TBL] [Abstract][Full Text] [Related]
14. Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein.
Degen WG; Pieffers M; Welin-Henriksson E; van den Hoogen FH; van Venrooij WJ; Raats JM
Eur J Immunol; 2000 Oct; 30(10):3029-38. PubMed ID: 11069087
[TBL] [Abstract][Full Text] [Related]
15. The U1 snRNP complex: an autoantigen in connective tissue diseases. An update.
Klein Gunnewiek JM; van de Putte LB; van Venrooij WJ
Clin Exp Rheumatol; 1997; 15(5):549-60. PubMed ID: 9307865
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease.
Hof D; Cheung K; de Rooij DJ; van den Hoogen FH; Pruijn GJ; van Venrooij WJ; Raats JM
Arthritis Res Ther; 2005; 7(2):R302-9. PubMed ID: 15743477
[TBL] [Abstract][Full Text] [Related]
17. Basophils and IgE contribute to mixed connective tissue disease development.
Lamri Y; Vibhushan S; Pacreau E; Boedec E; Saidoune F; Mailleux A; Crestani B; Blank U; Benhamou M; Papo T; Daugas E; Sacré K; Charles N
J Allergy Clin Immunol; 2021 Apr; 147(4):1478-1489.e11. PubMed ID: 33338538
[TBL] [Abstract][Full Text] [Related]
18. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target.
Fatenejad S; Brooks W; Schwartz A; Craft J
J Immunol; 1994 Jun; 152(11):5523-31. PubMed ID: 7514640
[TBL] [Abstract][Full Text] [Related]
19. The fate of the U1 snRNP autoantigen during apoptosis: implications for systemic autoimmunity.
Malmegrim KC; Pruijn GJ; van Venrooij WJ
Isr Med Assoc J; 2002 Sep; 4(9):706-12. PubMed ID: 12440236
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cells target epitopes residing within the RNA-binding domain of the U1-70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease.
Greidinger EL; Zang YJ; Jaimes K; Martinez L; Nassiri M; Hoffman RW
J Immunol; 2008 Jun; 180(12):8444-54. PubMed ID: 18523312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
